Vanguard Portfolio Management
DERM icon

Vanguard Portfolio Management’s Journey Medical DERM Stock Holding History

Vanguard Portfolio Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-122,245
Closed -$573K – 3171
2026
Q1 		$573K Buy
+122,245
New +$949K ﹤0.01% 2931

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Portfolio Management's DERM Position: Q2 2026 in Review

Vanguard Portfolio Management sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 122,245 shares — an estimated $573K sold.

Vanguard Portfolio Management first reported a position in DERM in Q1 2026 and held it in 1 quarter. The position peaked at $573K in Q1 2026. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Vanguard Portfolio Management reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • Vanguard Portfolio Management sold 122,245 Journey Medical shares in Q2 2026, an estimated $573K.
  • Vanguard Portfolio Management first reported a position in Journey Medical in Q1 2026 and held it in 1 quarter.
  • Vanguard Portfolio Management's Journey Medical position peaked at $573K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.